Medicare Enrolled
Dr. Salaam Alobeidy, MD
Critical Care Medicine · Galloway, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alobeidy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alobeidy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alobeidy
Dr. Salaam Alobeidy is a critical care medicine specialist in Galloway, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Alobeidy performed 6,229 Medicare services across 3,500 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alobeidy received a total of $15,035 from 45 pharmaceutical and/or device companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alobeidy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in NJ
$15,035 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,229
Medicare services
Top 3% in NJ for critical care medicine
3,500
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~328 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,561 | $142 | $275 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
788 | $23 | $108 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
696 | $45 | $179 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
689 | $46 | $179 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
631 | $98 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
448 | $103 | $225 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
280 | $27 | $175 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
236 | $33 | $95 |
| New patient office visit, complex (60-74 min) | 156 | $166 | $449 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
140 | $143 | $275 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $72 | $150 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
105 | $27 | $75 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
99 | $128 | $329 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
54 | $49 | $150 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
49 | $222 | $600 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
41 | $91 | $280 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $120 | $200 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 30 | $63 | $195 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
26 | $142 | $400 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $67 | $200 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
11 | $15 | $58 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,035
Total received (2018-2024)
Avg $2,148/year across 7 years
Top 9% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
450
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,521 (56.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,515 (43.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,630
2023
$1,928
2022
$4,335
2021
$3,315
2020
$2,645
2019
$753
2018
$429
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$277
Mylan Specialty L.P.
$253
AstraZeneca Pharmaceuticals LP
$222
Actelion Pharmaceuticals US, Inc.
$162
ABBVIE INC.
$92
Philips North America LLC
$67
Bayer Healthcare Pharmaceuticals Inc.
$60
JAZZ PHARMACEUTICALS INC.
$52
Avadel CNS Pharmaceuticals, LLC
$51
Regeneron Healthcare Solutions, Inc.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Inspire Medical Systems, Inc.
$41
United Therapeutics Corporation
$37
ANI Pharmaceuticals, Inc.
$35
Insmed, Inc.
$34
Optinose US, Inc.
$32
Pulmonx Corporation
$24
Resmed Corp
$20
Merck Sharp & Dohme LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Electromed, Inc.
$16
Amgen Inc.
$16
HARMONY BIOSCIENCES LLC
$14
Top 3 companies account for 46.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$9,454
Mylan Specialty L.P.
$1,056
GlaxoSmithKline, LLC.
$714
Actelion Pharmaceuticals US, Inc.
$604
Philips Electronics North America Corporation
$344
Insmed, Inc.
$242
Boehringer Ingelheim Pharmaceuticals, Inc.
$235
AbbVie Inc.
$188
Takeda Pharmaceuticals U.S.A., Inc.
$166
JAZZ PHARMACEUTICALS INC.
$153
Amgen Inc.
$140
GENZYME CORPORATION
$131
United Therapeutics Corporation
$125
Bayer Healthcare Pharmaceuticals Inc.
$113
ABBVIE INC.
$92
ANI Pharmaceuticals, Inc.
$84
Genentech USA, Inc.
$81
Regeneron Healthcare Solutions, Inc.
$78
Sunovion Pharmaceuticals Inc.
$69
Philips North America LLC
$67
Avadel CNS Pharmaceuticals, LLC
$67
Bayer HealthCare Pharmaceuticals Inc.
$67
Merck Sharp & Dohme LLC
$62
Harmony Biosciences LLC
$54
Merck Sharp & Dohme Corporation
$53
Resmed Corp
$51
Optinose US, Inc.
$49
Electromed, Inc.
$43
Mallinckrodt Hospital Products Inc.
$42
Inspire Medical Systems, Inc.
$41
Eisai Inc.
$41
Gilead Sciences, Inc.
$35
Baxter Healthcare
$34
Axsome Therapeutics, Inc.
$30
Jazz Pharmaceuticals Inc.
$30
Pharming Healthcare, Inc.
$30
Grifols USA, LLC
$30
HARMONY BIOSCIENCES LLC
$26
Pulmonx Corporation
$24
Teva Pharmaceuticals USA, Inc.
$18
Advanced Respiratory, Inc
$17
Allergan Inc.
$15
EISAI INC.
$14
Circassia Pharmaceuticals Inc
$12
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 74.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · Adempas · AirCurve · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · DALIRESP · DALVANCE · DUPIXENT · Dayvigo · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · INSPIRE · LONHALA MAGNAIR · LUMRYZ · NUCALA · OFEV · OPSUMIT · PURIFIED CORTROPHIN GEL · Prolastin-C Liquid · RUCONEST · Respiratoriy Care Undiv · SMARTVEST · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Tracleer · UPTRAVI · WAKIX · WINREVAIR · Wakix · XYREM · XYWAV · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for critical care medicine in NJ.
Geographic Context
Critical care medicines within 10 mi
12
Per 100K population
4.4
County median income
$76,819
Nearest hospital
ATLANTICARE REGIONAL MEDICAL CENTER - CITY CAMPUS
7.2 mi
7.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alobeidy is a clinical cardiology specialist, with above-average Medicare volume (top 3% in NJ), with speaking/promotional industry engagement in the top 9% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alobeidy experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Alobeidy performed 1,561 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alobeidy receive payments from pharmaceutical companies?
Yes. Dr. Alobeidy received a total of $15,035 from 45 companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alobeidy's costs compare to other critical care medicines in Galloway?
Dr. Alobeidy's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alobeidy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Galloway
Browse critical care medicines in Galloway ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NJ
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NJ
Which NJ critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology